Pharmacokinetics of ibuprofen in patients with cystic fibrosis

Pharmacotherapy

Volumn 19, Issue 3, 1999, Pages 340-345

  Murry, Daryl J ^a   Oermann, Christopher M ^a   Ou, Ching Nan ^a   Rognerud, Cheryl ^a   Seilheimer, Dan K ^a   Sockrider, Marianna M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY SURFACE; BODY WEIGHT; CHILD; COMPARTMENT MODEL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISTRIBUTION VOLUME; DOSE CALCULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RELIABILITY;

EID: 0032980461     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.4.340.30944     Document Type: Article

References (18)

1. Eigen H, Rosenstein BJ. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. J Pediatr 1995;126:515-23.
2. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332:848-54.
3. Dove AM, Szefler SJ, Hill MR, Jusko WJ, Larsen GL, Accurso FJ. Altered prednisolone pharmacokinetics in patients with cystic fibrosis. J Pediatr 1992;120:789-94.
4. Konstan MW, Hoppel CL, Chai B, Davis PB. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. J Pediatr 1991;118:956-64.
5. Anonymous. Ibuprofen: information for cystic fibrosis physicians. Bethesda, MD: Cystic Fibrosis Foundation, 1995.
6. Ou CN, Rognerud CL. Liquid chromatographic method for indomethacin and other inflammatory drugs. Clin Chem 1989;35:1164.
7. D'Argenio DZ, Schumitzky A. ADAPT II user's guide: pharmacokinetic/pharmacodynamic systems analysis software. Los Angeles: Biomedical Simulations Resource, 1997.
8. Gehan EA, George SL. Estimation of human body surface area from height and weight. Part 1. Cancer Chemother Rep 1970;54:225-35.
9. Devine BJ. Gentamicin therapy. Drug Intell Clin Pharm 1974;8:650-5.
10. Traub SL, Kichon L. Estimating ideal body mass in children. Am J Hosp Pharm 1983;40:107-10.
11. Murry DJ, Crom WR, Reddick WE, Bhargava R, Evans WE. Liver volume as a determinant of drug clearance in children and adolescents. Drug Metab Dispos 1995;23:1110-16.
12. Kearns GL. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions. Ann Pharmacother 1993;27:74-9.
13. Spino M. Pharmacokinetics of drugs in cystic fibrosis. Clin Rev Allergy 1991;9:169-210.
14. Prandota J. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis. Drugs 1988;35:542-78.
15. de Groot R, Smith AL. Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. Clin Pharmacokinet 1987;13:228-53.
16. Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage Implications for drug therapy. Clin Pharmacokinet 1994;26:292-307.
17. Brown RD, Wilson JT, Kearns GL, Eichler VF, Johnson VA, Bertrand KM. Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol 1992;32:231-41.
18. Scott C, Retsch-Bogart G, Kustra R, Johnson B, Dong J, Smith P. Pharmacokinetics of ibuprofen suspension in young children with cystic fibrosis. Pediatr Pulmonol 1997;24(suppl 14):319-20.